SCHEMBL19711547

SCHEMBL19711547

Ic1cncc2c1CNCC2

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
PNMT P11086 11/20 0.39
ADRA2A P08913 2/20 0.39
ADRA2B P18089 2/20 0.39
ADRA2C P18825 2/20 0.39
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
CD44 P16070 1/20 0.36
MAOB P27338 1/20 0.36
PRCP P42785 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19684585 0.77 CHRNB2 (0.41) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL19667229 0.77 PNMT (0.44) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL25281145 0.74 PNMT (0.46) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL30183105 0.74 PNMT (0.46) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL19678853 0.73 CHRNB2 (0.38) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL30207837 0.73 PNMT (0.48) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL19667407 0.73 PNMT (0.48) CHRNB2CHRNA4PNMTADRA2AADRA2B
Hydrochloric Acid SCHEMBL25281366 0.73 PNMT (0.45) CHRNB2CHRNA4PNMTADRA2AADRA2B
Hydrochloric Acid SCHEMBL31186539 0.73 PNMT (0.45) CHRNB2CHRNA4PNMTADRA2AADRA2B
SCHEMBL19711565 0.71 PNMT (0.53) PNMTADRA2AADRA2BADRA2CCD44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464249-B1 SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER (US) 2021-08-11 EP disclosed
WO-2017213825-A1 TREATMENT METHODS HAVING REDUCED DRUG-RELATED TOXICITY AND METHODS OF IDENTIFYING THE LIKELIHOOD OF PATIENT HARM FROM PRESCRIBED MEDICATIONS TABULA RASA HEALTHCARE, INC. (US) 2017-12-14 WO disclosed